findmyKOL

David Wohl, MD

Enriched profile

Professor of Medicine, Division of Infectious Diseases · University of North Carolina at Chapel Hill

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Chapel Hill, NC · Southeast · United StatesSpecialtyInfectious DiseaseFocusHIV
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding1997–2026

David Wohl is Professor of Medicine, Division of Infectious Diseases at University of North Carolina at Chapel Hill. OpenAlex indexes 471 publications with 12,001 citations (h-index 57); ClinicalTrials.gov lists 10 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

David Wohl, MD, is Professor of Medicine, Division of Infectious Diseases at University of North Carolina at Chapel Hill, School of Medicine, Division of Infectious Diseases. The public record shows 471 publications with 12,001 citations (h-index 57), centered on HIV. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 9 companies, 13 NIH-funded awards (1997–2026).

  • Most recent indexed publication: 2026 · Open forum infectious diseases
  • Top research focus: HIV
  • 10 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 9 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
HIV10 trialsHIV Infections5 trialsLymphoma1 trialSarcoma1 trialAcquired Immunodeficiency Syndrome1 trialLymphoma, Non-Hodgkin1 trialSarcoma, Kaposi1 trialComa1 trialLymphoma, AIDS-Related1 trialVirus Diseases1 trialCytomegalovirus Infections1 trialLipodystrophy1 trial

Research focus

OpenAlex concept fingerprint
HIV

Drugs & molecules

across trials, industry payments and publications
EnsitrelvirClinical trials—Industry payments1Publications1Symtuzageneric · Cobicistat / darunavir / emtricitabine / tenofovir alafenamideClinical trials—Industry payments26Publications—Sunlencageneric · LenacapavirClinical trials—Industry payments12Publications—Veklurygeneric · RemdesivirClinical trials—Industry payments9Publications—Egriftageneric · TesamorelinClinical trials—Industry payments7Publications—Serostimgeneric · SomatropinClinical trials—Industry payments7Publications—Delstrigogeneric · Doravirine / lamivudine / tenofovir disoproxilClinical trials—Industry payments6Publications—Pifeltrogeneric · DoravirineClinical trials—Industry payments6Publications—Biktarvygeneric · Bictegravir / emtricitabine / tenofovir alafenamideClinical trials—Industry payments3Publications—Dovatogeneric · Dolutegravir / lamivudineClinical trials—Industry payments3Publications—Trogarzogeneric · IbalizumabClinical trials—Industry payments2Publications—CabenuvaClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Gilead Sciences, Inc.Clinical trials—Industry payments148ViiV Healthcare CompanyClinical trials—Industry payments56Merck Sharp & Dohme LLCClinical trials—Industry payments40Janssen Products, LPClinical trials—Industry payments16EMD Serono, Inc.Clinical trials—Industry payments13Janssen Scientific Affairs, LLCClinical trials—Industry payments12Theratechnologies Inc.Clinical trials—Industry payments9Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments8National Institute of Allergy and Infectious Diseases (NIAID)Clinical trials4Industry payments—Advancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsClinical trials2Industry payments—David A Wohl, MDClinical trials1Industry payments—Duke UniversityClinical trials1Industry payments—National Center for Complementary and Integrative Health (NCCIH)Clinical trials1Industry payments—Shionogi IncClinical trials—Industry payments1University of North Carolina, Chapel HillClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
471publications

Distinct works indexed by OpenAlex, matched via ORCID; 30 in PubMed.

12,001citations

Total citations across indexed works.

57h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
10clinical trials

Investigator role on registered studies.

View trials ↓
9companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
13NIH grants · 1997–2026

Federally funded research awards.

View funding ↓

Public positions

sourced statements on record
  • Co-author

    "HIV and Mass Incarceration: Where Infectious Diseases and Social Justice Meet," North Carolina Medical Journal (2016), argues for reform of HIV criminal laws and addressing drivers of mass incarceration

    2016
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hivlawandpolicy.org ↗
  • Member

    US Department of Health and Human Services (DHHS) Antiretroviral Guidelines Panel, served two terms

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:

All 10 trial records: search, sort and filter.Explore →

Industry payments

Updated 14 Oct 2026

9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 25 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    39.5%
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor18.9%
    Tivicay63%Dovato14%Isentress13%Cabenuva7%Juluca4%
    Part D<11 patients
    Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor11%
    Descovy100%
    Part D≥18 patients

    + 3 more classes in this area

  • Nervous system

    25.7%
    Opioid Agonist6.1%
    Oxycodone Hcl52%Methadone Hcl48%
    Part D<11 patients
    Gabapentinoids4.7%
    Gabapentin84%Pregabalin16%
    Part D<11 patients

    + 8 more classes in this area

  • Cardiovascular

    18.6%
    Statin8.4%
    Atorvastatin Calcium92%Pravastatin Sodium9%
    Part D<11 patients
    Calcium channel blocker4.3%
    Amlodipine Besylate100%
    Part D<11 patients

    + 3 more classes in this area

All 7 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)45.1% facility · 54.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

13 NIH research awards on record, funded 1997–2026 per NIH RePORTER. The latest:

All 174 award records: search, sort and filter.Explore →

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 30 publications: search, sort and filter.Explore →

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/david-wohl-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/unchealthcare/posts/unc-health-infectious-disease-expert-dr-david-wohl-was-interviewed-by-wncn-about/1324491806385299

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗
  • Instagram

    instagram.com/uncdeptmedicine

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com ↗
  • Other

    en.wikipedia.org/wiki/David_A._Wohl

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
  • Other

    med.unc.edu/medicine/news/chairs-corner/podcast/living-a-long-life-with-hiv

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
  • Other

    thebodypro.com/collection/future-hiv-care-podcast

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →thebodypro.com ↗
  • X / Twitter

    twitter.com/uncdeptmedicine

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →twitter.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Rutgers Robert Wood Johnson Medical School

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
  • Internal medicine residency

    Duke University; Infectious Diseases fellowship, University of North Carolina at Chapel Hill

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
  • Board certified

    Internal Medicine and Infectious Disease (ABIM), exact certification years not independently confirmed on a primary UNC page …

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

Editorial & leadership roles

journal and society appointments
  • Co-Director

    UNC Viral Hemorrhagic Fever Research Group; founder, UNC Project Liberia

    2014
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
  • Co-Principal Investigator

    Global UNC Infectious Diseases Clinical Trials Unit; Site Leader, Chapel Hill research site

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
  • Site Leader

    UNC AIDS Clinical Trials Unit at Chapel Hill

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
  • Director

    North Carolina AIDS Education and Training Center (AETC)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
  • Co-Director of HIV Services

    North Carolina Department of Corrections (state prison system)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗

Awards & honors

honors on the public record
  • Charles van der Horst Humanitarian Award

    AIDS Clinical Trials Group (ACTG), inaugural recipient, 2020, recognized for advocacy, research, treatment and care of infectious diseases

    2020
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.